Mylan sells its 5.64% Biocon stake within six months, institutional...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...
New Delhi: This has been a significant milestone in the long-term process of changing the leadership of the company because Kiran Mazumdar-Shaw, the founder and chairperson of the company, has...
Mumbai: With Novo Nordisk’s Semaglutide patent due for expiry in various markets, India’s leading generic drugs manufacturer Biocon has signed a licensing agreement with Ajanta Pharma to market its version...
New Delhi: Bangalore Outer Ring Road (ORR) is once again in the limelight because of traffic congestion, particularly around the Iblur crossing during the rush hours. Karnataka Chief Minister Siddaramaiah...
New Delhi: Biocon, an Indian pharmaceuticals giant, registered Rs 3,516 crore in revenues for Quarter 1 of FY 2024. An official statement issued by the company said that the profits were...